546 related articles for article (PubMed ID: 20152822)
41. 5% Me2SO is sufficient to preserve stem cells derived from cord blood.
Richter E; Eichler H; Raske D; Leveringhaus A; Zieger W; Kerowgan M; Goldmann SF
Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S16. PubMed ID: 9715875
[TBL] [Abstract][Full Text] [Related]
42. Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.
Almici C; Carlo-Stella C; Wagner JE; Mangoni L; Garau D; Re A; Giachetti R; Cesana C; Rizzoli V
Bone Marrow Transplant; 1997 Jun; 19(11):1079-84. PubMed ID: 9193749
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of DMSO dextrose as a suitable alternative for DMSO dextran in cord blood cryopreservation.
Raffo D; Perez Tito L; Pes ME; Fernandez Sasso D
Vox Sang; 2019 Apr; 114(3):283-289. PubMed ID: 30734294
[TBL] [Abstract][Full Text] [Related]
44. Cryopreservation of rat hepatocytes with disaccharides for cell therapy.
Cardoso LMDF; Pinto MA; Henriques Pons A; Alves LA
Cryobiology; 2017 Oct; 78():15-21. PubMed ID: 28782503
[TBL] [Abstract][Full Text] [Related]
45. Optimal length of time of cryopreserved umbilical cord blood infusion after thawing.
Huang L; Song GQ; Wu Y; Wang J; Sun ZM
Hematology; 2014 Mar; 19(2):73-9. PubMed ID: 23684058
[TBL] [Abstract][Full Text] [Related]
46. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO.
Lakota J; Fuchsberger P
Bone Marrow Transplant; 1996 Jul; 18(1):262-3. PubMed ID: 8832035
[No Abstract] [Full Text] [Related]
47. Effects of cell banking manipulations on ex vivo amplification of umbilical cord blood.
Forte L; Migliaccio G; Sanchez M; Migliaccio AR; Passarelli AM; Amadori S
Ann Ist Super Sanita; 2000; 36(3):333-42. PubMed ID: 11293302
[TBL] [Abstract][Full Text] [Related]
48. Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation.
M-Reboredo N; Díaz A; Castro A; Villaescusa RG
Bone Marrow Transplant; 2000 Dec; 26(12):1263-70. PubMed ID: 11223965
[TBL] [Abstract][Full Text] [Related]
49. Characterization of cryobiological responses in TF-1 cells using interrupted freezing procedures.
Ross-Rodriguez LU; Elliott JA; McGann LE
Cryobiology; 2010 Apr; 60(2):106-16. PubMed ID: 19766619
[TBL] [Abstract][Full Text] [Related]
50. Improved postthaw viability and in vitro functionality of peripheral blood hematopoietic progenitor cells after cryopreservation with a theoretically optimized freezing curve.
Tijssen MR; Woelders H; de Vries-van Rossen A; van der Schoot CE; Voermans C; Lagerberg JW
Transfusion; 2008 May; 48(5):893-901. PubMed ID: 18298597
[TBL] [Abstract][Full Text] [Related]
51. Assessment of cord blood hematopoietic cell parameters before and after cryopreservation.
Kurtz J; Seetharaman S; Greco N; Moroff G
Transfusion; 2007 Sep; 47(9):1578-87. PubMed ID: 17725720
[TBL] [Abstract][Full Text] [Related]
52. The effect of freezing on the recovery and expansion of umbilical cord blood hematopoietic stem cells.
Beshlawy AE; Metwally HG; Khalek KA; Hammoud RF; Mousa SM
Exp Clin Transplant; 2009 Mar; 7(1):50-5. PubMed ID: 19364313
[TBL] [Abstract][Full Text] [Related]
53. Polyunsaturated fatty acids confer cryoresistance on megakaryocytes generated from cord blood and also enhance megakaryocyte production from cryopreserved cord blood cells.
Shabrani NC; Khan NF; Kale VP; Limaye LS
Cytotherapy; 2012 Mar; 14(3):366-80. PubMed ID: 22250991
[TBL] [Abstract][Full Text] [Related]
54. Cryopreservation of peripheral blood progenitor cells: characteristics of suitable techniques.
Sputtek A; Jetter S; Hummel K; Kühnl P
Beitr Infusionsther Transfusionsmed; 1997; 34():79-83. PubMed ID: 9356660
[TBL] [Abstract][Full Text] [Related]
55. Trehalose ameliorates the cryopreservation of cord blood in a preclinical system and increases the recovery of CFUs, long-term culture-initiating cells, and nonobese diabetic-SCID repopulating cells.
Zhang XB; Li K; Yau KH; Tsang KS; Fok TF; Li CK; Lee SM; Yuen PM
Transfusion; 2003 Feb; 43(2):265-72. PubMed ID: 12559024
[TBL] [Abstract][Full Text] [Related]
56. The effect of processing and cryopreservation on nucleated umbilical cord blood cells.
Bayer-Zwirello LA; Hoffman DE; Adams LA; Wilder PT; Reece MT
J Perinat Med; 2004; 32(5):430-3. PubMed ID: 15493721
[TBL] [Abstract][Full Text] [Related]
57. [Improved method for delivery room collection and storage of human cord blood cells for grafting].
Szołomicka-Kurzawa P
Ann Acad Med Stetin; 2001; 47():107-24. PubMed ID: 12514905
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the Ceprate LC34 affinity system for the enrichment of CD34+ hematopoietic stem cells from cord blood.
Kögler G; Somville T; Werner P
Blood Cells; 1994; 20(2-3):371-5. PubMed ID: 7538341
[TBL] [Abstract][Full Text] [Related]
59. Inhibiting ice recrystallization and optimization of cell viability after cryopreservation.
Chaytor JL; Tokarew JM; Wu LK; Leclère M; Tam RY; Capicciotti CJ; Guolla L; von Moos E; Findlay CS; Allan DS; Ben RN
Glycobiology; 2012 Jan; 22(1):123-33. PubMed ID: 21852258
[TBL] [Abstract][Full Text] [Related]
60. High sensitivity of megakaryocytic progenitor cells contained in placental/umbilical cord blood to the stresses during cryopreservation.
Xu Y; Kashiwakura I; Takahashi TA
Bone Marrow Transplant; 2004 Sep; 34(6):537-43. PubMed ID: 15273713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
